explore -WSS

explore

author：leisure time 2025-09-30 00:03:46 - browse：44

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： U.K. Biobank has 500,000 peoples' genome sequences available

WSS

With clinical trial data readouts, here's how to spot spin

FDA investigates CAR

'Essentially witchcraft:' A former naturopath takes on the field

As biotech industry slumps, bioscience job market is upside down

Organ aging and disease risk measured by new blood test

With clinical trial data readouts, here's how to spot spin

knowledge

explore

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The EPA's new lead rule: How one expert crunched the numbers

After affirmative action ruling, medical educators look to 'holistic review'

U.K. Biobank has 500,000 peoples' genome sequences available

The cancer drug shortage isn’t new — and neither are the solutions

CDC director unscathed in first congressional testimony

Affirmative action in medical school literally saved lives

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Peter Hotez and the public health issue of online harassment

Study: Why relieving medical debt did not improve financial outcomes

focus

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

New report analyzes digital physical therapy solutions' effectiveness

Report captures long Covid’s disabling effects and policy challenges

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

ReNAgade cuts staff seven months after raising $300 million

30 years of 'Listening to Prozac'

explore

explore

hotspot

leisure time